ALISON L. HANNAH
CIK 1645600 · EVP, Chief Medical Officer · last filed 2026-07-10
ALISON L. HANNAH is an EVP, Chief Medical Officer who has filed 32 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for RIGL, was dated Jul 10, 2026. Across all open-market trades the lifetime net is +$244.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.22M
3
32
$244.8K
Holdings By Company
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-10 | RIGL | Grant (A) | +24,400 | $0 | EDGAR |
| 2026-05-19 | RIGL | Grant (A) | +5,750 | $0 | EDGAR |
| 2025-06-03 | NEO | Mixed | +12,254 | $0 | EDGAR |
| 2025-06-03 | NEO | Exer (M) | +12,254 | $0 | EDGAR |
| 2025-05-28 | RIGL | Grant (A) | +2,500 | $0 | EDGAR |
| 2024-08-13 | NEO | Exer (M) | +11,336 | $0 | EDGAR |
| 2024-06-04 | NEO | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-08-14 | NEO | Grant (A) | — | $0 | EDGAR |
| 2023-07-12 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.